Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorDUBREUCQ, Julien
dc.contributor.authorPLASSE, Julien
dc.contributor.authorGABAYET, Franck
dc.contributor.authorFARALDO, M.
dc.contributor.authorBLANC, Olivier
dc.contributor.authorCHEREAU, Isabelle
dc.contributor.authorCERVELLO, Sophie
dc.contributor.authorCOUHET, Geoffroy
dc.contributor.authorDEMILY, Caroline
dc.contributor.authorGUILLARD-BOUHET, Nathalie
dc.contributor.authorGOUACHE, Benjamin
dc.contributor.authorJAAFARI, N.
dc.contributor.authorLEGRAND, Guillaume
dc.contributor.authorLEGROS-LAFARGE, Emilie
dc.contributor.authorPOMMIER, R.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorQUILES, Clelia
dc.contributor.authorSTRAUB, D.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorVERDOUX, Helene
dc.contributor.authorVIGNAGA, Francis
dc.contributor.authorMASSOUBRE, Catherine
dc.contributor.authorFRANCK, Nicolas
dc.date.accessioned2021-01-22T09:04:28Z
dc.date.available2021-01-22T09:04:28Z
dc.date.issued2020
dc.identifier.issn0924-9338en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/25953
dc.description.abstractEnBackground. Self-stigma is a major issue in serious mental illness (SMI) and is negatively associated with patient outcomes. Most studies have been conducted in schizophrenia (SZ). Less is known about self-stigma in other SMI and autism spectrum disorder (ASD). The objectives of this study are: (i) to assess the frequency of self-stigma in a multicentric nonselected psychiatric rehabilitation SMI and ASD sample; and (ii) to investigate the correlates of elevated self-stigma in different SMI conditions and in ASD. Methods. A total of 738 SMI or ASD outpatients were recruited from the French National Centers of Reference for Psychiatric Rehabilitation cohort (REHABase). Evaluations included sociodemographic data, illness characteristics, and standardized scales for clinical severity, quality of life, satisfaction with life, wellbeing, personal recovery, a large cognitive battery, and daily functioning assessment. Results. 31.2% of the total sample had elevated self-stigma. The highest prevalence (43.8%) was found in borderline personality disorder and the lowest (22.2%) in ASD. In the multivariate analysis, elevated self-stigma was best predicted by early stages of personal recovery (moratorium, p = 0.001, OR = 4.0 [1.78–8.98]; awareness, p = 0.011, OR = 2.87 [1.28–6.44]), history of suicide attempt (p = 0.001, OR = 2.27 [1.37–3.76]), insight (p = 0.002, OR = 1.22 [1.08–1.38]), wellbeing (p = 0.037, OR = 0.77 [0.60–0.98]), and satisfaction with interpersonal relationships (p < 0.001, OR = 0.85 [0.78–0.93]). Conclusions. The present study has confirmed the importance of addressing self-stigma in SMI and ASD patients enrolled in psychiatric rehabilitation. The effectiveness of psychiatric rehabilitation on self-stigma and the potential mediating effects of changes in self-stigma on treatment outcomes should be further investigated.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectPharmacoEpi-Drugs
dc.title.enSelf-stigma in serious mental illness and autism spectrum disorder: Results from the REHABase national psychiatric rehabilitation cohort
dc.title.alternativeEur Psychiatryen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1192/j.eurpsy.2019.12en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed32093806en_US
bordeaux.journalEuropean Psychiatryen_US
bordeaux.pagee13en_US
bordeaux.volume63en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03118320
hal.version1
hal.date.transferred2021-01-22T09:04:33Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=European%20Psychiatry&amp;rft.date=2020&amp;rft.volume=63&amp;rft.issue=1&amp;rft.spage=e13&amp;rft.epage=e13&amp;rft.eissn=0924-9338&amp;rft.issn=0924-9338&amp;rft.au=DUBREUCQ,%20Julien&amp;PLASSE,%20Julien&amp;GABAYET,%20Franck&amp;FARALDO,%20M.&amp;BLANC,%20Olivier&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée